| 18/12/2007 |
HELSINN WILL PRESENT AT THE 26th ANNUAL J.P. MORGAN HEALTHCARE CONFERENCE, SAN FRANCISCO
|
|
| 30/10/2007 |
HELSINN HEALTHCARE AND MGI PHARMA ANNOUNCE SUBMISSION OF SUPPLEMENTAL NEW DRUG APPLICATION FOR ALOXI® ORAL CAPSULES
|
|
| 29/10/2007 |
HELSINN AND MAELOR ANNOUNCE A LICENSE AGREEMENT FOR ALOXI® (PALONOSETRON) IN THE UK
|
|
| 25/10/2007 |
HELSINN HEALTHCARE AT THE 14th EUROPEAN CANCER CONFERENCE (ECCO) Barcelona, 23-27 September 2007
|
|
| 25/10/2007 |
Helsinn Chemicals SA obtains accreditation by Pharmaceuticals and Medical Devices Agency (PMDA)
|
|
| 18/10/2007 |
HELSINN HEALTHCARE PRESENTS NEW DATA ON ORIGINAL NIMESULIDE AT THE WORLD INSTITUTE OF PAIN (WIP) CONGRESS (BUDAPEST, 25 SEPTEMBER, 2007)
|
|
| 16/10/2007 |
ALOXI® PHASE 3 DATA FOR POST OPERATIVE NAUSEA AND VOMITING (PONV) PRESENTED AT THE ANNUAL MEETING OF THE AMERICAN SOCIETY OF ANESTHESIOLOGISTS (ASA)
|
|
| 21/09/2007 |
The CHMP/EMEA has confirmed that the benefit/risk profile of Nimesulide is positive
|
|
| 04/09/2007 |
HELSINN AND MGI PHARMA ANNOUNCE ALOXI® sNDA APPROVAL ALLOWING FOR REPEATED DOSING FOR CANCER PATIENTS RECEIVING MULTIPLE DAY CHEMOTHERAPY REGIMENS
|
|
| 18/07/2007 |
Outcome of Helsinn's participation in ASCO 2007, Chicago 1-5 June and MASCC 2007, St. Gallen, 27-30 June
|
|
| 13/07/2007 |
Helsinn participates in the conference at San Raffaele Biomedical Science Park, Milan, 29th June 2007 - Helsinn partecipa alla conferenza al Parco Scientifico San Raffaele, Milano, 29 giugno 2007
|
|
| 10/07/2007 |
Helsinn announces Aloxi sNDA for PONV accepted for review by U.S. FDA - PDUFA date of 4th March 2008 established
|
|
| 05/06/2007 |
New data on Aloxi® presented at the ASCO Annual Meeting, Chicago 1-5 June 2007
|
|
| 25/05/2007 |
EMEA REFERRAL PROCEDURE ON NIMESULIDE
|
|
| 17/05/2007 |
Helsinn Healthcare SA, nimesulide is a safe drug
|
|
| 15/05/2007 |
SUSPENSION OF NIMESULIDE FROM THE IRISH MARKET, PENDING EU CHMP SCIENTIFIC REVIEW
|
|
| 07/05/2007 |
HELSINN ANNOUNCES SUBMISSION OF SUPPLEMENTAL NEW DRUG APPLICATION FOR ALOXI® INJECTION IN POST-OPERATIVE NAUSEA AND VOMITING IN USA
|
|
| 21/03/2007 |
HELSINN HEALTHCARE AND PIERRE FABRE AQUITAINE: ANOTHER STEP FORWARD IN THEIR BUSINESS RELATIONSHIP
|
|
| 09/03/2007 |
HELSINN’S PARTICIPATION IN INFORMEX 2007
|
|
| 13/02/2007 |
HELSINN HEALTHCARE SA ANNOUNCES PATENT EXTENSION FOR ALOXI® INJECTION IN THE U.S.
|
|
| 22/01/2007 |
Aloxi - Launched in Nordic Countries
|
|
| 17/01/2007 |
Helsinn Co-Managing Director Enrico Braglia steps down
|
|
